Skip to main content
. 2018 Aug 6;41(10):2220–2228. doi: 10.2337/dc18-0774

Table 2.

Dietary recall and activity prior to visit, biomarker AUC, visit activity, and energy intake comparison by condition

Variable SIT SIT + WALK P
Total 24-h diet recall
 Total energy intake (kcal/day) 1,951.3 (651.6) 2,047.5 (570.0) 0.413
 Carbohydrate intake (%)1 52.7 (9.3) 51.9 (7.9) 0.697
 Fat intake (%)1 33.1 (8.5) 32.5 (7.5) 0.766
 Protein intake (%)1 14.1 (4.2) 15.6 (4.5) 0.051
Wrist accelerometry (week prior to testing)
 Number of valid days of data 6.9 (2.2) 6.6 (2.4) 0.982
 Wear time (h/day) 22.1 (2.0) 22.2 (1.6) 0.988
 Daily activity (3-D counts/day × 10−6) 3.2 (0.61) 3.20 (0.59) 0.606
 Total sleep time (h/night) 7.5 (0.7) 7.6 (0.7) 0.146
 Sleep efficiency (%) 86.7 (4.0) 86.5 (4.7) 0.850
Metabolic outcomes from OGTT
 Insulin AUC (mIU/dL ∙ min)2,3 21,145.9 (18,280.7) 16,629.9 (17,563.0) <0.001
 C-peptide AUC (ng/dL ∙ min)2,3 14,778.5 (900.9) 1,205.7 (527.8) 0.001
 Glucose AUC (mg/dL ∙ min)2,3 21,587.7 (2,215.5) 21,106.5 (2,630.4) 0.143
 FFA AUC (mEq/L ∙ min)2,3 34.6 (11.0) 31.1 (11.4) 0.074
 Cortisol AUC (µg/dL ∙ min)2,3 1,165.0 (229.2) 1,175.6 (292.0) 0.973
 Triglycerides AUC (mg/dL ∙ min)2,3,4 16,033.6 (10,580.3) 15,969.0 (8,857.3) 0.442
 Matsuda index of insulin sensitivity3 3.64 (2.18) 4.26 (2.51) 0.013
 GE index3 4.04 (1.0) 3.99 (1.02) 0.124
Catecholamines during OGTT (pg/dL)5
 Norepinephrine baseline3 255.0 (65.9) 243.7 (75.9) 0.527
 Norepinephrine at 30 min3 268.6 (62.1) 401.4 (128.4) <0.001
 Epinephrine baseline3 32.9 (17.3) 34.6 (16.4) 0.591
 Epinephrine at 30 min3 26.0 (10.1) 33.7 (25.3) 0.283
 Dopamine baseline 25.9 (3.9) 25.2 (0.64) 0.384
 Dopamine at 30 min 25.8 (2.6) 25.6 (2.9) 0.779
Buffet energy intake after OGTT
 Total energy intake (kcal) 1,261.9 (480.4) 1,259.6 (474.9) 0.890
 Carbohydrate intake (%)1 49.7 (9.4) 49.2 (8.4) 0.383
 Fat intake (%)1 38.2 (7.7) 38.7 (6.7) 0.379
 Protein intake (%)1 12.1 (2.9) 12.2 (2.9) 0.558

Data are mean (SD). P value determined with repeated-measures ANOVA controlling for randomization order, age, sex, fat mass, and puberty stage. n = 32–35 unless noted. Boldface type indicates significant P values.

1Arcsine (square root) transformed for analysis.

2AUC by trapezoidal rule.

3Log transformed for analysis.

4Additionally controlled for race.

5n = 24.